接受体外受精的生育力低下女性中全胚冷冻指征:一项队列研究
本研究为西班牙24家辅助生殖中心开展的多中心前瞻性观察研究,纳入2021年2月至2022年7月间1034例接受体外受精或卵胞浆内单精子注射的生育力低下女性。全胚冷冻策略在794例(78.1%)中有指征,最常见原因为计划胚胎植入前遗传学检测(490/794,61.7%)和卵巢过度刺激综合征风险(192/794,24.2%)。
要点
- 1034例中794例(78.1%)有全胚冷冻指征,计划胚胎植入前遗传学检测占61.7%。
- 卵巢过度刺激综合征风险为第二位指征,占192/794(24.2%)。
- 709例首次胚胎移植中,冻胚移植577例(81.4%),鲜胚移植132例(18.6%)。
核心结论
- 研究队列中首选治疗策略为冷冻全部可用胚胎,主要原因为计划胚胎植入前遗传学检测和避免卵巢过度刺激综合征风险。
研究设计与样本
- 多中心前瞻性观察研究,纳入西班牙24家辅助生殖治疗中心中年龄≥18岁、有体外受精或卵胞浆内单精子注射临床指征的生育力低下女性。
- 患者于2021年2月至2022年7月纳入,随访至确认妊娠(持续妊娠,≥20周)或冷冻保存后6个月。
- 主要终点为冷冻全部可用胚胎的患者比例及主要指征,共1034例可评估女性(平均±标准差年龄36.3±4.1岁)。
主要发现
- 生育力低下主要原因:男性因素301/1034(29.1%),母亲年龄277/1034(26.8%)。
- 采用FSH联合高纯度尿源性人绝经期促性腺激素/LH进行卵巢刺激者466/906(51.4%)。
- 垂体降调节方面,多数女性704/881(79.9%)使用促性腺激素释放激素拮抗剂加尼瑞克。
- 全胚冷冻策略在794例(78.1%)中有指征,最常见原因为计划胚胎植入前遗传学检测(490/794,61.7%)和卵巢过度刺激综合征风险(192/794,24.2%)。
- 分析的709例首次胚胎移植中,鲜胚移植132例(18.6%),冻胚移植577例(81.4%);至第三次胚胎移植,每次胚胎移植的临床妊娠和持续妊娠累积率分别为72.2%(436/604)和62.9%(317/504)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: How widely is the freeze-all strategy implemented in clinical practice, and what are its indications? DESIGN: This multicentre, prospective observational study included women aged ≥18 years with subfertility and a clinical indication for IVF or intracytoplasmic sperm injection (ICSI) across 24 Spanish assisted reproductive treatment (ART) centres. Patients were included between February 2021 and July 2022, and followed-up until confirmation of pregnancy (ongoing pregnancy, ≥20 weeks) or 6 months after cryopreservation. The primary endpoint was the proportion of patients who cryopreserved all available embryos and the main indications. RESULTS: The population comprised 1034 evaluable women (mean ± SD age 36.3 ± 4.1 years). The main causes of subfertility were male factor (301/1034, 29.1%) and maternal age (277/1034, 26.8%). Ovarian stimulation with FSH plus highly purified urinary human menopausal gonadotrophin/LH was performed in 466/906 (51.4%) women. For pituitary down-regulation, most women (704/881, 79.9%) received the gonadotrophin-releasing hormone antagonist ganirelix. The freeze-all strategy was indicated in 794 (78.1%) patients, with the most common reasons being planned preimplantation genetic testing (490/794, 61.7%) and risk of ovarian hyperstimulation syndrome (192/794, 24.2%). Of the 709 first embryo transfers analysed, 132 (18.6%) were fresh embryo transfers and 577 (81.4%) were frozen embryo transfers. By the third embryo transfer, the cumulative rates of clinical and ongoing pregnancy per embryo transfer were 72.2% (436/604) and 62.9% (317/504), respectively. CONCLUSIONS: The preferred treatment strategy in the study cohort was to freeze all available embryos, mainly because of planned preimplantation genetic testing and to avoid the risk of ovarian hyperstimulation syndrome.
引用
- Moens V, Fontes Jiménez J, Ferrando Serrano M, et al. Freeze-all indications in women with subfertility undergoing IVF: a cohort study. Reprod Biomed Online. 2024. PMID: 40081305. doi:10.1016/j.rbmo.2024.104491
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。